Elevance Health, Inc. (LON:0HG8)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 75.77B |
| Revenue (ttm) | 141.23B |
| Net Income (ttm) | 4.78B |
| Shares Out | n/a |
| EPS (ttm) | 20.51 |
| PE Ratio | 15.86 |
| Forward PE | n/a |
| Dividend | 5.13 (1.21%) |
| Ex-Dividend Date | Mar 10, 2025 |
| Volume | 8 |
| Average Volume | 1,340 |
| Open | 424.21 |
| Previous Close | 427.74 |
| Day's Range | 424.21 - 424.21 |
| 52-Week Range | 412.30 - 516.42 |
| Beta | 0.87 |
| RSI | 63.40 |
| Earnings Date | Apr 16, 2025 |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial numbers in USD Financial StatementsNews
44th Move: Anthem review – veers admirably from the beaten path
(Black Acre) Pianist and producer Alfa Mist’s latest project, with drummer Richard Spaven, showcases two musicians at the top of their game In the London jazz scene of the past decade, pianist and pro...
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future growth. Read why ELV stock remains a Buy.
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 15 Years
Elevance Health (NYSE: ELV) has outperformed the market over the past 15 years by 2.24% on an annualized basis producing an average annual return of 13.22%. Currently, Elevance Health has a market ca...
Elevance Health gains after CFO comments at investor event
Top Companies for Social Responsibility
Intel heads the list, followed by Elevance Health and Accenture
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last art...
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, res...
Elevance Health Inc (ELV) Stock Price Up 3.38% on Feb 25
Elevance Health Inc (ELV) Stock Price Up 3.38% on Feb 25
Is the Market Bullish or Bearish on Elevance Health?
Elevance Health's (NYSE: ELV) short percent of float has fallen 3.97% since its last report. The company recently reported that it has 2.81 million shares sold short , which is 1.21% of all regular s...
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong r...
Stocks to watch for: Elevance Health, Accenture PLC and more
Chad Morganlander, senior portfolio manager at Washington Crossing Advisors, shares his outlook on promising stocks in the health and tech sectors.
Elevance Health Bolsters Employer Insurance Business
Elevance Health says its acquisition of Verily's Granular Insurance Company is designed to bolster its offerings to self-funded employer clients. Financial terms of the deal aren't being disclosed, an...
Alphabet’s Verily in pact with Elevance Health to offload insurance business
Alphabet's Verily Sells Granular Insurance To Elevance Health Amid Healthcare Strategy Refocus
Verily , Alphabet Inc. ‘s (NASDAQ: GOOGL) (NASDAQ: GOOG) health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, Granular Insurance Company , to Elevance Heal...
Alphabet's Verily to sell Granular insurance business to Elevance Health
Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health.
Verily enters an agreement to sell its insurance business to Elevance Health
Verily CEO Stephen Gillett told staff that the company's Granular insurance business is to be acquired by Elevance Health.
Elevance Health Foundation Announces New Five-Year, $150 Million Commitment
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation today announces its new five-year, $150 million commitment aimed at addressing the physical, behavioral, and social needs of under-resourced c...
My Top 15 High-Growth Dividend Stocks For February 2025
The SPDR S&P 500 ETF Trust starts 2025 on a positive note gaining 2.67% in January. The Top 15 dividend growth stocks for February 2025 offer an average dividend yield of 1.64% and appear to be about ...
Trump gives a lift to healthcare stocks with comments on Medicare and Medicaid
Trump has pledged to protect Social Security and Medicare throughout his campaign, one analyst noted, but this was the first time he added Medicaid to the list.
Elevance Health: Trading At Depressed Levels, So We Added Modestly
We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click here to read more.
How Is The Market Feeling About Elevance Health?
Elevance Health's (NYSE: ELV) short percent of float has risen 5.37% since its last report. The company recently reported that it has 3.63 million shares sold short , which is 1.57% of all regular sh...
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
ELV earnings call for the period ending December 31, 2024.
Elevance Health, Inc. (ELV) Q4 2024 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q4 2024 Earnings Conference Call January 23, 2025 8:30 AM ETCompany ParticipantsNathan Rich - VP, IRGail Boudreaux -...
Elevance Health, Inc. 2024 Q4 - Results - Earnings Call Presentation
The following slide deck was published by Elevance Health, Inc.
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.